Articles by Jane Wan - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jane Wan

Healthcare Reform in China

Chinese healthcare reforms may be a double-edged sword for foreign companies.
Sep 2, 2014

Chinese healthcare reforms may be a double-edged sword for foreign companies.

Brunei's Potential Pharmaceutical Market Growth

Brunei harnesses its rich biodiversity and the growing halal market in a bid to develop its pharmaceutical sector.
Jun 2, 2014

Brunei harnesses its rich biodiversity and the growing halal market in a bid to develop its pharmaceutical sector.

Pharma Industry Corruption in China Under Scrutiny

China's regulatory and compliance environment is set to change as the government declares a crackdown on bribery scandals.
Apr 1, 2014

China's regulatory and compliance environment is set to change as the government declares a crackdown on bribery scandals.

Regulators Get Tough on Corruption in China

China's regulatory and compliance environment is set to change as the government declares a crackdown on bribery scandals.
Mar 2, 2014

China's regulatory and compliance environment is set to change as the government declares a crackdown on bribery scandals.

Clinical Trials Head East to Asia

Companies remain optimistic about the clinical-trials industry in Asia despite its challenges.
Dec 2, 2013

The rising cost of drug development and the decreasing proportion of drug-naive population in the US and European markets are driving international pharmaceutical companies to consider emerging markets as a location to conduct their clinical trials. Asia stands out among the emerging markets given its double-digit growth rates.

Report from Myanmar

Foreign companies zero in on Myanmar with the hope of securing a foothold in its pharmaceutical market.
Oct 2, 2013

Foreign companies zero in on Myanmar with the hope of securing a foothold in its pharmaceutical market.

Report from India

Industry players brace themselves to face challenges as India's new drug-pricing policy kicks in full gear.
Aug 2, 2013

Industry players brace themselves to face challenges as India's new drug-pricing policy kicks in full gear.

Report from Taiwan

The Taiwanese government engages in regulatory science in a move to boost its pharmaceutical sector.
Jun 2, 2013

The Taiwanese government engages in regulatory science in a move to boost its pharmaceutical sector.

Report from Thailand

The Thai government is ramping up efforts to promote and develop the biotechnology sector in a bid to enhance its global competitiveness.
Apr 2, 2013

The Thai government is ramping up efforts to promote and develop the biotechnology sector in a bid to enhance its global competitiveness.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here